Head: Solodiannykova Oksana I.. To develop radionuclide and cytological determinants for evaluating the effectiveness of targeted therapy of iodine-negative metastases of differentiated thyroid cancer.
National Cancer Institute. № 0122U002452
Updated: 2026-10-23